Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celldex Therapeutics SVPs Engage In Heavy Transactions


On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.

Transaction value based on SEC Form 4 reported price ($29.09); post-Transaction value based on Dec. 4, 2025 market close ($29.09).

Continue reading


Source Fool.com

Celldex Therapeutics Stock

€38.34
1.290%
There is an upward development for Celldex Therapeutics compared to yesterday, with an increase of €0.49 (1.290%).
Currently there is a rather positive sentiment for Celldex Therapeutics with 18 Buy predictions and 3 Sell predictions.
As a result the target price of 40 € shows a slightly positive potential of 4.33% compared to the current price of 38.34 € for Celldex Therapeutics.
Like: 0
Share

Comments